Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSION PROTEIN INCLUDING GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON-LIKE PEPTIDE-2 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/015039
Kind Code:
A1
Abstract:
The present invention relates to a dimeric protein including glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) additionally plus IL-10 and a composition using same for treating neurodegenerative disease, especially Alzheimer's disease. The dimeric protein alleviates the deposition of amyloid beta plaque and has an excellent effect of improving memory and cognitive functions and as such, can be advantageously utilized for treating and preventing neurodegenerative disease, especially Alzheimer's disease and has high industrially utility.

Inventors:
JANG MYOUNG HO (KR)
LEE KYUNGWHA (KR)
KIM JI-HYUN (KR)
Application Number:
PCT/KR2021/009017
Publication Date:
January 20, 2022
Filing Date:
July 14, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GI INNOVATION INC (KR)
International Classes:
C07K14/605; A61K38/00; A61P25/16; A61P25/28; C07K14/54
Foreign References:
KR20080064840A2008-07-09
KR20160032699A2016-03-24
KR20160083810A2016-07-12
US20090186817A12009-07-23
US20140193407A12014-07-10
Attorney, Agent or Firm:
RYU, Jong Woo et al. (KR)
Download PDF: